Literature DB >> 1470842

Susceptibility of African isolates of Plasmodium falciparum to artemisinin (qinghaosu).

J C Doury1, P Ringwald, J Guelain, J Le Bras.   

Abstract

We studied in vitro susceptibility of 79 African strains of Plasmodium falciparum to artemisinin, chloroquine, quinine, mefloquine and halofantrine and the potential cross-resistance among the drugs. Most strains presented an 50% inhibitory concentration (IC50) of artemisinin below 26 nmol/liter. A positive correlation between IC50S of artemisinin and those of quinine, mefloquine and halofantrine was observed. Cross resistance between artemisinin and other antimalarials may limit its use as a replacement drug.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470842

Source DB:  PubMed          Journal:  Trop Med Parasitol        ISSN: 0177-2392


  3 in total

Review 1.  Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria.

Authors:  P J de Vries; T K Dien
Journal:  Drugs       Date:  1996-12       Impact factor: 9.546

2.  In-vitro tests on Philippine isolates of Plasmodium falciparum against four standard antimalarials and four qinghaosu derivatives.

Authors:  M D Bustos; F Gay; B Diquet
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

Review 3.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.